Green Thumb Industries Stock Looks Stuck. Here's Why Wall Street Loves the Cannabis Stock Anyway.

James Halley, The Motley Fool

Mon, August 31, 2026 at 5:35 PM GMT+3 6 min read

There's a fundamental disconnect between what the general public thinks of cannabis multi-state operator (MSO) Green Thumb Industries (OTC: GTBIF) and what analysts think of it.

Shares of the Chicago-based company have fallen more than 5% so far this year, but analysts remain overwhelmingly bullish on it, maintaining an average price target of around $16, implying more than 100% upside.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

There are good reasons for that enthusiasm. Here are three reasons why analysts are bullish on the stock.

It has strong fundamentals and operational catalysts

Unlike many peers reliant on dilutive financing to stay afloat, Green Thumb generates positive net income per generally accepted accounting principles (GAAP) and solid free cash flow. Second-quarter revenue reached $307 million, up 4.6%, year over year, providing the company with a clean, liquid balance sheet to navigate market downturns. Net income was $4.9 million, compared to a loss of $645,000 in the same quarter a year ago.

The company has only $283 million in total debt, while it has $283.6 million in cash and cash equivalents.

On the negative side, earnings per share (EPS) were $0.02, up only slightly from a $0.01 loss in the same period a year ago and down from the $0.07 it reported in the first quarter.

The stock trades at less than 14 times trailing earnings. Capitalizing on what management sees as a heavily undervalued stock, Green Thumb has aggressively repurchased millions of shares, including 7.9 million shares in the quarter. This reduces total share count and boosts per-share earnings growth. Through Sept. 22, the company said it has the authority to buy back an additional $62.3 million worth of company stock.

Green Thumb has its RISE stores in 14 states and is expanding its retail store count in key medical and adult-use growth states, such as Florida and Nevada, as well as prospective adult-use markets, including Virginia and Texas.

The company operates one of Virginia's five vertically integrated pharmaceutical processor licenses through its RISE dispensaries. That gives it a head start once adult-use sales begin in the state. In Texas, which has more than 31 million people, only low-dose THC cannabis oil is available for approved medical use, and low-THC hemp products are allowed for recreational use. State authorities granted Green Thumb a vertically integrated medical cannabis permit. That allows the company to cultivate, process, and directly dispense low-THC medical cannabis to qualified patients.

Additionally, its entry into regulated hemp-derived THC beverages, landing shelf space in mainstream retailers in 18 states, opens up broader consumer channels.

Image source: Getty Images.

Its unique brands drive revenue beyond its RISE stores

Rather than relying solely on foot traffic at its more than 120 RISE dispensary locations, Green Thumb builds distinct consumer brands targeted at specific demographics and distributes them nationwide through wholesale channels.

Its consumer packaged goods span various entry points in the cannabis market. Its &Shine brand offers accessible, mid-tier vape cartridges and concentrates aimed at value-seeking daily consumers. At the top, Rythm is Green Thumb's premium brand, appealing to connoisseurs and frequent cannabis consumers looking for high-potency, strain-specific profiles.

Green Thumb sells its branded products directly to thousands of third-party dispensaries across the states where it holds cultivation and processing licenses. Independent retail owners buy Rythm flower or Incredibles gummies wholesale to supply their own shelves.

In the second quarter, its consumer packaged goods gross revenue grew 3.7% year over year, mainly because of the launch of adult-use sales in Minnesota and continued growth in existing markets, especially in New Jersey and Ohio, the company said.

Green Thumb runs more than 20 state-of-the-art production and processing facilities. Because cultivation scale reduces unit production costs, it can achieve high profit margins when selling bulk packaged goods to third-party retailers.

It stands to benefit more than others from rescheduling

Reclassifying marijuana from Schedule I to Schedule III would significantly ease tax burdens on cannabis retailers, allowing them to deduct standard business expenses like rent. It would eliminate the 280E tax burden, unlocking tens of millions of dollars in net cash flow. The U.S. Drug Enforcement Administration (DEA) recently concluded hearings on the rescheduling, but a final decision remains pending.

Once Section 280E tax penalties are eliminated, Green Thumb, as a larger MSO, stands to retain more operating cash flow. Its recent decisions, including filing DEA registration applications for its medical facilities and its growing share buyback program, show that the company is confident in its long-term strategy.

Betting on an industry leader

Cannabis sales are growing across the country, with more states allowing adult-use and medical-use sales. Not every cannabis company will last long enough to benefit, but Green Thumb, because of its size and stable finances, is positioned to ride the growing trend.

Cannabis stocks have been a roller-coaster ride for a while, but if you're looking for long-term potential, it makes sense to invest in an industry leader with a strong national presence such as Green Thumb Industries.

Should you buy stock in Green Thumb Industries right now?

Before you buy stock in Green Thumb Industries, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Green Thumb Industries wasn't one of them. The 10 stocks that made the cut are built for long-term growth and could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $440,710!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,335,252!*

That performance is why people listen. With a track record of beating the S&P 500 by nearly 5x, Stock Advisor offers a distinct advantage. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built for the long haul.

See the 10 stocks »

*Stock Advisor returns as of August 31, 2026.

James Halley has no position in any of the stocks mentioned. The Motley Fool recommends Green Thumb Industries. The Motley Fool has a disclosure policy.

Green Thumb Industries Stock Looks Stuck. Here's Why Wall Street Loves the Cannabis Stock Anyway. was originally published by The Motley Fool